XML 32 R32.htm IDEA: XBRL DOCUMENT v2.4.1.9
Intangible Assets - Additional Information (Detail) (USD $)
3 Months Ended 6 Months Ended 12 Months Ended
Mar. 31, 2015
Mar. 31, 2014
Mar. 31, 2015
Mar. 31, 2014
Sep. 30, 2014
Finite Lived Intangible Assets [Line Items]          
Amortization expense $ 155,366us-gaap_AmortizationOfIntangibleAssets $ 13,663us-gaap_AmortizationOfIntangibleAssets $ 169,030us-gaap_AmortizationOfIntangibleAssets $ 27,327us-gaap_AmortizationOfIntangibleAssets $ 54,653us-gaap_AmortizationOfIntangibleAssets
Amortization of license agreements remainder of fiscal year 2015 877,541us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear   877,541us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear    
Amortization of license agreements in 2016 1,714,313us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths   1,714,313us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths    
Amortization of license agreements in 2017 1,700,429us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo   1,700,429us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo    
Amortization of license agreements in 2018 1,700,429us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree   1,700,429us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree    
Amortization of license agreements in 2019 1,700,429us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour   1,700,429us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour    
Amortization of license agreements in 2020 1,700,429us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive   1,700,429us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive    
Amortization of license agreements, thereafter 15,363,152us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive   15,363,152us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive    
Novartis RNAi [Member] | Licensing Agreements          
Finite Lived Intangible Assets [Line Items]          
Amortization period of intangible assets     21 years    
Finite-lived intangible assets, accumulated amortization 12,367us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization
/ arwr_AssetAcquisitionAxis
= arwr_NovartisRNAiMember
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_LicensingAgreementsMember
  12,367us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization
/ arwr_AssetAcquisitionAxis
= arwr_NovartisRNAiMember
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_LicensingAgreementsMember
   
Novartis RNAi [Member] | Patents [Member]          
Finite Lived Intangible Assets [Line Items]          
Amortization period of intangible assets     14 years    
Finite-lived intangible assets, accumulated amortization 129,335us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization
/ arwr_AssetAcquisitionAxis
= arwr_NovartisRNAiMember
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_PatentsMember
  129,335us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization
/ arwr_AssetAcquisitionAxis
= arwr_NovartisRNAiMember
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_PatentsMember
   
Roche Madison [Member] | Licensing Agreements          
Finite Lived Intangible Assets [Line Items]          
Amortization period of intangible assets     4 years    
Finite-lived intangible assets, accumulated amortization $ 188,790us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization
/ arwr_AssetAcquisitionAxis
= arwr_RocheMadisonMember
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_LicensingAgreementsMember
  $ 188,790us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization
/ arwr_AssetAcquisitionAxis
= arwr_RocheMadisonMember
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_LicensingAgreementsMember